If you reference or share it, please provide a link back to Levity with proper attribution.
A health warning on repurposed drugs None of the above should be read to suggest and it is not DW's recommendation that anyone use GLP-1 agonists, or any other drug, to treat any "off label"/non-approved condition, without personal, professional medical advice
Eli Lilly reiterated to NPR that the drugs have been "available since August." "Our current manufacturing investment of over $20 billion in the past four years is the most significant in our history, and will allow us to continue increasing capacity to safely bring these medicines to people who need them," Eli Lilly spokesperson Courtney Kasinger wrote in an email
The initial shock to the system fades
Patients following bariatric surgery, GI disease, or with malabsorption syndromes